{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:27:56Z","timestamp":1783114076434,"version":"3.54.6"},"publisher-location":"Cham","reference-count":114,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031319778","type":"print"},{"value":"9783031319785","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-3-031-31978-5_30","type":"book-chapter","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:02:35Z","timestamp":1690837355000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathological Roles of INPP5D in Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Yung Ning","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aika","family":"Akahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"30_CR1","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, et al (2015) Alzheimer\u2019s disease. Nat Rev Dis Primers 1:15056. https:\/\/doi.org\/10.1038\/nrdp.2015.56","journal-title":"Nat Rev Dis Primers"},{"key":"30_CR2","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1:a006189. https:\/\/doi.org\/10.1101\/cshperspect.a006189","journal-title":"Cold Spring Harb Perspect Med"},{"key":"30_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1042\/bse0330117","volume":"33","author":"M Hutton","year":"1998","unstructured":"Hutton M, P\u00e9rez-Tur J, Hardy J (1998) Genetics of Alzheimer\u2019s disease. Essays Biochem 33:117\u201331. https:\/\/doi.org\/10.1042\/bse0330117","journal-title":"Essays Biochem"},{"key":"30_CR4","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nn.2858","volume":"14","author":"T Saito","year":"2011","unstructured":"Saito T, Suemoto T, Brouwers N, et al (2011) Potent amyloidogenicity and pathogenicity of A\u03b243. Nat Neurosci 14:1023\u201332. https:\/\/doi.org\/10.1038\/nn.2858","journal-title":"Nat Neurosci"},{"key":"30_CR5","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256:184\u20135. https:\/\/doi.org\/10.1126\/science.1566067","journal-title":"Science"},{"key":"30_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u20136. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, et al (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u20139. https:\/\/doi.org\/10.1038\/nature11283","journal-title":"Nature"},{"key":"30_CR8","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330:1774. https:\/\/doi.org\/10.1126\/science.1197623","journal-title":"Science"},{"key":"30_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, et al (2016) The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537:50\u20136. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"key":"30_CR10","doi-asserted-by":"publisher","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al (2022) Lecanemab in Early Alzheimer\u2019s Disease. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/NEJMoa2212948","DOI":"10.1056\/NEJMoa2212948"},{"key":"30_CR11","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, et al (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91:e859\u2013e866. https:\/\/doi.org\/10.1212\/WNL.0000000000006075","journal-title":"Neurology"},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","volume":"5","author":"A Mudher","year":"2017","unstructured":"Mudher A, Colin M, Dujardin S, et al (2017) What is the evidence that tau pathology spreads through prion-like propagation? Acta Neuropathol Commun 5:99. https:\/\/doi.org\/10.1186\/s40478-017-0488-7","journal-title":"Acta Neuropathol Commun"},{"key":"30_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","volume":"76","author":"GS Gibbons","year":"2019","unstructured":"Gibbons GS, Lee VMY, Trojanowski JQ (2019) Mechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review. JAMA Neurol 76:101\u2013108. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2505","journal-title":"JAMA Neurol"},{"key":"30_CR14","doi-asserted-by":"publisher","unstructured":"Andersen SL (2020) Centenarians as Models of Resistance and Resilience to Alzheimer\u2019s Disease and Related Dementias. Adv Geriatr Med Res 2: https:\/\/doi.org\/10.20900\/agmr20200018","DOI":"10.20900\/agmr20200018"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54:412\u2013436. https:\/\/doi.org\/10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"key":"30_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"30_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B de Strooper","year":"2016","unstructured":"de Strooper B, Karran E (2016) The Cellular Phase of Alzheimer\u2019s Disease. Cell 164:603\u201315. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056","journal-title":"Cell"},{"key":"30_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367\u2013402. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120240","journal-title":"Annu Rev Immunol"},{"key":"30_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052358","journal-title":"Annu Rev Immunol"},{"key":"30_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, et al (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74:691\u2013705. https:\/\/doi.org\/10.1016\/j.neuron.2012.03.026","journal-title":"Neuron"},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tcb.2016.02.006","volume":"26","author":"JL Frost","year":"2016","unstructured":"Frost JL, Schafer DP (2016) Microglia: Architects of the Developing Nervous System. Trends Cell Biol 26:587\u2013597. https:\/\/doi.org\/10.1016\/j.tcb.2016.02.006","journal-title":"Trends Cell Biol"},{"key":"30_CR22","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","volume":"28","author":"T Bolmont","year":"2008","unstructured":"Bolmont T, Haiss F, Eicke D, et al (2008) Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance. J Neurosci 28:4283\u201392. https:\/\/doi.org\/10.1523\/JNEUROSCI.4814-07.2008","journal-title":"J Neurosci"},{"key":"30_CR23","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/S41591-021-01456-W","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, et al (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27:1592\u20131599. https:\/\/doi.org\/10.1038\/S41591-021-01456-W","journal-title":"Nat Med"},{"key":"30_CR24","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neurobiolaging.2003.12.026","volume":"25","author":"MR D\u2019Andrea","year":"2004","unstructured":"D\u2019Andrea MR, Cole GM, Ard MD (2004) The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiol Aging 25:675\u201383. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.12.026","journal-title":"Neurobiol Aging"},{"key":"30_CR25","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1038\/ncomms7176","volume":"6","author":"C Condello","year":"2015","unstructured":"Condello C, Yuan P, Schain A, Grutzendler J (2015) Microglia constitute a barrier that prevents neurotoxic protofibrillar A\u03b242 hotspots around plaques. Nat Commun 6:6176. https:\/\/doi.org\/10.1038\/ncomms7176","journal-title":"Nat Commun"},{"key":"30_CR26","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493:674\u20138. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"key":"30_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352:712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","journal-title":"Science"},{"key":"30_CR28","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai H, Ikezu S, Tsunoda S, et al (2015) Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18:1584\u201393. https:\/\/doi.org\/10.1038\/nn.4132","journal-title":"Nat Neurosci"},{"key":"30_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, et al (2018) Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med 24:29\u201338. https:\/\/doi.org\/10.1038\/nm.4443","journal-title":"Nat Med"},{"key":"30_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, et al (2019) TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci 22:1217\u20131222. https:\/\/doi.org\/10.1038\/s41593-019-0433-0","journal-title":"Nat Neurosci"},{"key":"30_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u201393. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nat Genet"},{"key":"30_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"J-C Lambert","year":"2009","unstructured":"Lambert J-C, Heath S, Even G, et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20139. https:\/\/doi.org\/10.1038\/ng.439","journal-title":"Nat Genet"},{"key":"30_CR33","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA, et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832\u201340. https:\/\/doi.org\/10.1001\/jama.2010.574","journal-title":"JAMA"},{"key":"30_CR34","doi-asserted-by":"publisher","unstructured":"Hansen D v., Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217:459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","DOI":"10.1083\/jcb.201709069"},{"key":"30_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, et al (2013) TREM2 Variants in Alzheimer\u2019s Disease. New England Journal of Medicine 368:117\u2013127. https:\/\/doi.org\/10.1056\/NEJMoa1211851","journal-title":"New England Journal of Medicine"},{"key":"30_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMOA1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368:107\u2013116. https:\/\/doi.org\/10.1056\/NEJMOA1211103","journal-title":"N Engl J Med"},{"key":"30_CR37","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.4049\/jimmunol.164.10.4991","volume":"164","author":"A Bouchon","year":"2000","unstructured":"Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991\u20135. https:\/\/doi.org\/10.4049\/jimmunol.164.10.4991","journal-title":"J Immunol"},{"key":"30_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/J.NEURON.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich JD, Ulland TK, Colonna M, Holtzman DM (2017) Elucidating the Role of TREM2 in Alzheimer\u2019s Disease. Neuron 94:237\u2013248. https:\/\/doi.org\/10.1016\/J.NEURON.2017.02.042","journal-title":"Neuron"},{"key":"30_CR39","doi-asserted-by":"publisher","unstructured":"Yeh FL, Hansen D v., Sheng M (2017) TREM2, Microglia, and Neurodegenerative Diseases. Trends Mol Med 23:512\u2013533. https:\/\/doi.org\/10.1016\/j.molmed.2017.03.008","DOI":"10.1016\/j.molmed.2017.03.008"},{"key":"30_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M (2018) TREM2 \u2014 a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 14:667\u2013675. https:\/\/doi.org\/10.1038\/s41582-018-0072-1","journal-title":"Nat Rev Neurol"},{"key":"30_CR41","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/J.CELL.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I (2020) The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway. Cell 181:1207\u20131217. https:\/\/doi.org\/10.1016\/J.CELL.2020.05.003","journal-title":"Cell"},{"key":"30_CR42","doi-asserted-by":"publisher","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, et al (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6: https:\/\/doi.org\/10.1126\/scitranslmed.3009093","DOI":"10.1126\/scitranslmed.3009093"},{"key":"30_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, et al (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160:1061\u201371. https:\/\/doi.org\/10.1016\/j.cell.2015.01.049","journal-title":"Cell"},{"key":"30_CR44","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, et al (2016) TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron 91:328\u201340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015","journal-title":"Neuron"},{"key":"30_CR45","doi-asserted-by":"publisher","unstructured":"Kober DL, Alexander-Brett JM, Karch CM, et al (2016) Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms. Elife 5: https:\/\/doi.org\/10.7554\/eLife.20391","DOI":"10.7554\/eLife.20391"},{"key":"30_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","volume":"13","author":"W Song","year":"2017","unstructured":"Song W, Hooli B, Mullin K, et al (2017) Alzheimer\u2019s disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation. Alzheimer\u2019s & Dementia 13:381\u2013387. https:\/\/doi.org\/10.1016\/j.jalz.2016.07.004","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"30_CR47","doi-asserted-by":"publisher","first-page":"12634","DOI":"10.1074\/jbc.RA118.002352","volume":"293","author":"A Sudom","year":"2018","unstructured":"Sudom A, Talreja S, Danao J, et al (2018) Molecular basis for the loss-of-function effects of the Alzheimer\u2019s disease\u2013associated R47H variant of the immune receptor TREM2. Journal of Biological Chemistry 293:12634\u201312646. https:\/\/doi.org\/10.1074\/jbc.RA118.002352","journal-title":"Journal of Biological Chemistry"},{"key":"30_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.20142322","volume":"212","author":"TR Jay","year":"2015","unstructured":"Jay TR, Miller CM, Cheng PJ, et al (2015) TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models. J Exp Med 212:287\u201395. https:\/\/doi.org\/10.1084\/jem.20142322","journal-title":"J Exp Med"},{"key":"30_CR49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, et al (2016) TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 90:724\u2013739. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.003","journal-title":"Neuron"},{"key":"30_CR50","doi-asserted-by":"publisher","unstructured":"Lee S-H, Meilandt WJ, Xie L, et al (2021) Trem2 restrains the enhancement of tau accumulation and neurodegeneration by \u03b2-amyloid pathology. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2021.02.010","DOI":"10.1016\/j.neuron.2021.02.010"},{"key":"30_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, et al (2017) A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell 169:1276\u20131290.e17. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"key":"30_CR52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, et al (2017) The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47:566\u2013581.e9. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"key":"30_CR53","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1016\/j.cell.2022.09.030","volume":"185","author":"H Ennerfelt","year":"2022","unstructured":"Ennerfelt H, Frost EL, Shapiro DA, et al (2022) SYK coordinates neuroprotective microglial responses in neurodegenerative disease. Cell 185:4135\u20134152.e22. https:\/\/doi.org\/10.1016\/j.cell.2022.09.030","journal-title":"Cell"},{"key":"30_CR54","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","volume":"185","author":"S Wang","year":"2022","unstructured":"Wang S, Sudan R, Peng V, et al (2022) TREM2 drives microglia response to amyloid-\u03b2 via SYK-dependent and -independent pathways. Cell 185:4153\u20134169.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.09.033","journal-title":"Cell"},{"key":"30_CR55","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC-C, et al (2017) TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell 170:649\u2013663.e13. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023","journal-title":"Cell"},{"key":"30_CR56","doi-asserted-by":"publisher","first-page":"eabe5640","DOI":"10.1126\/scitranslmed.abe5640","volume":"13","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wind K, Wiedemann T, et al (2021) Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Sci Transl Med 13:eabe5640. https:\/\/doi.org\/10.1126\/scitranslmed.abe5640","journal-title":"Sci Transl Med"},{"key":"30_CR57","doi-asserted-by":"publisher","first-page":"e11227","DOI":"10.15252\/emmm.201911227","volume":"12","author":"K Schlepckow","year":"2020","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, et al (2020) Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med 12:e11227. https:\/\/doi.org\/10.15252\/emmm.201911227","journal-title":"EMBO Mol Med"},{"key":"30_CR58","doi-asserted-by":"publisher","unstructured":"Wang S, Mustafa M, Yuede CM, et al (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model. J Exp Med 217: https:\/\/doi.org\/10.1084\/jem.20200785","DOI":"10.1084\/jem.20200785"},{"key":"30_CR59","doi-asserted-by":"publisher","unstructured":"Jain N, Lewis CA, Ulrich JD, Holtzman DM (2023) Chronic TREM2 activation exacerbates A\u03b2-associated tau seeding and spreading. Journal of Experimental Medicine 220: https:\/\/doi.org\/10.1084\/jem.20220654","DOI":"10.1084\/jem.20220654"},{"key":"30_CR60","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, Ibrahim-Verbaas CA, Harold D, et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"30_CR61","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1038\/tp.2014.2","volume":"4","author":"A Ruiz","year":"2014","unstructured":"Ruiz A, Heilmann S, Becker T, et al (2014) Follow-up of loci from the International Genomics of Alzheimer\u2019s Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry 4:e358. https:\/\/doi.org\/10.1038\/tp.2014.2","journal-title":"Transl Psychiatry"},{"key":"30_CR62","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1212\/WNL.0000000000002909","volume":"87","author":"JM Farfel","year":"2016","unstructured":"Farfel JM, Yu L, Buchman AS, et al (2016) Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology 87:489\u201396. https:\/\/doi.org\/10.1212\/WNL.0000000000002909","journal-title":"Neurology"},{"key":"30_CR63","doi-asserted-by":"publisher","first-page":"69225","DOI":"10.18632\/oncotarget.12648","volume":"7","author":"H Jing","year":"2016","unstructured":"Jing H, Zhu J-X, Wang H-F, et al (2016) INPP5D rs35349669 polymorphism with late-onset Alzheimer\u2019s disease: A replication study and meta-analysis. Oncotarget 7:69225\u201369230. https:\/\/doi.org\/10.18632\/oncotarget.12648","journal-title":"Oncotarget"},{"key":"30_CR64","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3233\/JAD-140729","volume":"43","author":"X Wang","year":"2015","unstructured":"Wang X, Lopez OL, Sweet RA, et al (2015) Genetic determinants of disease progression in Alzheimer\u2019s disease. J Alzheimers Dis 43:649\u201355. https:\/\/doi.org\/10.3233\/JAD-140729","journal-title":"J Alzheimers Dis"},{"key":"30_CR65","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming Y, Li Z, Kapoor M, et al (2017) Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol 133:839\u2013856. https:\/\/doi.org\/10.1007\/s00401-017-1685-y","journal-title":"Acta Neuropathol"},{"key":"30_CR66","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-180512","volume":"66","author":"M Ramos de Matos","year":"2018","unstructured":"Ramos de Matos M, Ferreira C, Herukka S-K, et al (2018) Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer\u2019s Disease Cerebrospinal Fluid Biomarkers. J Alzheimers Dis 66:639\u2013652. https:\/\/doi.org\/10.3233\/JAD-180512","journal-title":"J Alzheimers Dis"},{"key":"30_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2019.06.003","volume":"81","author":"X Yao","year":"2019","unstructured":"Yao X, Risacher SL, Nho K, et al (2019) Targeted genetic analysis of cerebral blood flow imaging phenotypes implicates the INPP5D gene. Neurobiol Aging 81:213\u2013221. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.06.003","journal-title":"Neurobiol Aging"},{"key":"30_CR68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-020-00755-7","volume":"13","author":"M-S Tan","year":"2021","unstructured":"Tan M-S, Yang Y-X, Xu W, et al (2021) Associations of Alzheimer\u2019s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration. Alzheimers Res Ther 13:15. https:\/\/doi.org\/10.1186\/s13195-020-00755-7","journal-title":"Alzheimers Res Ther"},{"key":"30_CR69","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4:147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"key":"30_CR70","doi-asserted-by":"publisher","unstructured":"Ishida K, Yamada K, Nishiyama R, et al (2022) Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration. J Exp Med 219: https:\/\/doi.org\/10.1084\/jem.20211275","DOI":"10.1084\/jem.20211275"},{"key":"30_CR71","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.ajhg.2021.01.012","volume":"108","author":"C Robins","year":"2021","unstructured":"Robins C, Liu Y, Fan W, et al (2021) Genetic control of the human brain proteome. The American Journal of Human Genetics 108:400\u2013410. https:\/\/doi.org\/10.1016\/j.ajhg.2021.01.012","journal-title":"The American Journal of Human Genetics"},{"key":"30_CR72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13024-015-0048-1","volume":"10","author":"M Malik","year":"2015","unstructured":"Malik M, Parikh I, Vasquez JB, et al (2015) Genetics ignite focus on microglial inflammation in Alzheimer\u2019s disease. Mol Neurodegener 10:52. https:\/\/doi.org\/10.1186\/s13024-015-0048-1","journal-title":"Mol Neurodegener"},{"key":"30_CR73","doi-asserted-by":"publisher","unstructured":"Liu T, Zhu B, Liu Y, et al (2020) Multi-omic comparison of Alzheimer\u2019s variants in human ESC-derived microglia reveals convergence at APOE. J Exp Med 217: https:\/\/doi.org\/10.1084\/jem.20200474","DOI":"10.1084\/jem.20200474"},{"key":"30_CR74","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.V91.8.2753.2753_2753_2759","volume":"91","author":"Q Liu","year":"1998","unstructured":"Liu Q, Shalaby F, Jones J, et al (1998) The SH2-containing inositol polyphosphate 5-phosphatase, ship, is expressed during hematopoiesis and spermatogenesis. Blood 91:2753\u20139","journal-title":"Blood"},{"key":"30_CR75","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1073\/pnas.93.4.1689","volume":"93","author":"JE Damen","year":"1996","unstructured":"Damen JE, Liu L, Rosten P, et al (1996) The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A 93:1689\u201393. https:\/\/doi.org\/10.1073\/pnas.93.4.1689","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR76","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1101\/gad.10.9.1084","volume":"10","author":"MN Lioubin","year":"1996","unstructured":"Lioubin MN, Algate PA, Tsai S, et al (1996) p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 10:1084\u201395. https:\/\/doi.org\/10.1101\/gad.10.9.1084","journal-title":"Genes Dev"},{"key":"30_CR77","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","volume":"93","author":"T Balla","year":"2013","unstructured":"Balla T (2013) Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation. Physiol Rev 93:1019\u20131137. https:\/\/doi.org\/10.1152\/physrev.00028.2012","journal-title":"Physiol Rev"},{"key":"30_CR78","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1101\/gad.14.5.505","volume":"14","author":"LR Rohrschneider","year":"2000","unstructured":"Rohrschneider LR, Fuller JF, Wolf I, et al (2000) Structure, function, and biology of SHIP proteins. Genes Dev 14:505\u201320","journal-title":"Genes Dev"},{"key":"30_CR79","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/bbrc.1997.7538","volume":"239","author":"X Pesesse","year":"1997","unstructured":"Pesesse X, Deleu S, de Smedt F, et al (1997) Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun 239:697\u2013700. https:\/\/doi.org\/10.1006\/bbrc.1997.7538","journal-title":"Biochem Biophys Res Commun"},{"key":"30_CR80","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1182\/blood-2002-03-0787","volume":"100","author":"K Nakamura","year":"2002","unstructured":"Nakamura K, Malykhin A, Coggeshall KM (2002) The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. Blood 100:3374\u201382. https:\/\/doi.org\/10.1182\/blood-2002-03-0787","journal-title":"Blood"},{"key":"30_CR81","doi-asserted-by":"publisher","unstructured":"Ono M, Bolland S, Tempst P, Ravetch J v (1996) Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383:263\u20136. https:\/\/doi.org\/10.1038\/383263a0","DOI":"10.1038\/383263a0"},{"key":"30_CR82","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.4049\/jimmunol.1402874","volume":"195","author":"N Blanco-Men\u00e9ndez","year":"2015","unstructured":"Blanco-Men\u00e9ndez N, del Fresno C, Fernandes S, et al (2015) SHIP-1 Couples to the Dectin-1 hemITAM and Selectively Modulates Reactive Oxygen Species Production in Dendritic Cells in Response to Candida albicans. J Immunol 195:4466\u20134478. https:\/\/doi.org\/10.4049\/jimmunol.1402874","journal-title":"J Immunol"},{"key":"30_CR83","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1074\/jbc.272.14.8983","volume":"272","author":"L Liu","year":"1997","unstructured":"Liu L, Damen JE, Hughes MR, et al (1997) The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J Biol Chem 272:8983\u20138. https:\/\/doi.org\/10.1074\/jbc.272.14.8983","journal-title":"J Biol Chem"},{"key":"30_CR84","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fimmu.2012.00226","volume":"3","author":"MD Blunt","year":"2012","unstructured":"Blunt MD, Ward SG (2012) Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities. Front Immunol 3:226. https:\/\/doi.org\/10.3389\/fimmu.2012.00226","journal-title":"Front Immunol"},{"key":"30_CR85","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1182\/blood-2007-03-079699","volume":"110","author":"CJ Ong","year":"2007","unstructured":"Ong CJ, Ming-Lum A, Nodwell M, et al (2007) Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110:1942\u20131949. https:\/\/doi.org\/10.1182\/blood-2007-03-079699","journal-title":"Blood"},{"key":"30_CR86","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/s0960-9822(02)00511-0","volume":"6","author":"WM Kavanaugh","year":"1996","unstructured":"Kavanaugh WM, Pot DA, Chin SM, et al (1996) Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr Biol 6:438\u201345. https:\/\/doi.org\/10.1016\/s0960-9822(02)00511-0","journal-title":"Curr Biol"},{"key":"30_CR87","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1182\/blood.v98.7.2028","volume":"98","author":"Z Tu","year":"2001","unstructured":"Tu Z, Ninos JM, Ma Z, et al (2001) Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5\u2019-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98:2028\u201338. https:\/\/doi.org\/10.1182\/blood.v98.7.2028","journal-title":"Blood"},{"key":"30_CR88","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1006\/geno.2000.6324","volume":"69","author":"I Wolf","year":"2000","unstructured":"Wolf I, Lucas DM, Algate PA, Rohrschneider LR (2000) Cloning of the genomic locus of mouse SH2 containing inositol 5-phosphatase (SHIP) and a novel 110-kDa splice isoform, SHIPdelta. Genomics 69:104\u201312. https:\/\/doi.org\/10.1006\/geno.2000.6324","journal-title":"Genomics"},{"key":"30_CR89","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1182\/blood.V89.6.1876","volume":"89","author":"SJ Geier","year":"1997","unstructured":"Geier SJ, Algate PA, Carlberg K, et al (1997) The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89:1876\u201385","journal-title":"Blood"},{"key":"30_CR90","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/eji.201646795","volume":"47","author":"SD Pauls","year":"2017","unstructured":"Pauls SD, Marshall AJ (2017) Regulation of immune cell signaling by SHIP1: A phosphatase, scaffold protein, and potential therapeutic target. Eur J Immunol 47:932\u2013945. https:\/\/doi.org\/10.1002\/eji.201646795","journal-title":"Eur J Immunol"},{"key":"30_CR91","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/emboj\/17.7.1973","volume":"17","author":"AC Fluckiger","year":"1998","unstructured":"Fluckiger AC, Li Z, Kato RM, et al (1998) Btk\/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J 17:1973\u201385. https:\/\/doi.org\/10.1093\/emboj\/17.7.1973","journal-title":"EMBO J"},{"key":"30_CR92","doi-asserted-by":"publisher","unstructured":"Bolland S, Pearse RN, Kurosaki T, Ravetch J v (1998) SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509\u201316. https:\/\/doi.org\/10.1016\/s1074-7613(00)80555-5","DOI":"10.1016\/s1074-7613(00)80555-5"},{"key":"30_CR93","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","volume":"3","author":"Q Peng","year":"2010","unstructured":"Peng Q, Malhotra S, Torchia JA, et al (2010) TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1. Sci Signal 3:ra38. https:\/\/doi.org\/10.1126\/scisignal.2000500","journal-title":"Sci Signal"},{"key":"30_CR94","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1101\/gad.12.11.1610","volume":"12","author":"CD Helgason","year":"1998","unstructured":"Helgason CD, Damen JE, Rosten P, et al (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 12:1610\u201320. https:\/\/doi.org\/10.1101\/gad.12.11.1610","journal-title":"Genes Dev"},{"key":"30_CR95","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/gut.2009.202283","volume":"60","author":"WG Kerr","year":"2011","unstructured":"Kerr WG, Park M-Y, Maubert M, Engelman RW (2011) SHIP deficiency causes Crohn\u2019s disease-like ileitis. Gut 60:177\u201388. https:\/\/doi.org\/10.1136\/gut.2009.202283","journal-title":"Gut"},{"key":"30_CR96","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/mi.2014.32","volume":"7","author":"MY Park","year":"2014","unstructured":"Park MY, Srivastava N, Sudan R, et al (2014) Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice. Mucosal Immunol 7:1429\u20131439. https:\/\/doi.org\/10.1038\/mi.2014.32","journal-title":"Mucosal Immunol"},{"key":"30_CR97","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/nyas.12091","volume":"1280","author":"S Iyer","year":"2013","unstructured":"Iyer S, Margulies BS, Kerr WG (2013) Role of SHIP1 in bone biology. Ann N Y Acad Sci 1280:11\u20134. https:\/\/doi.org\/10.1111\/nyas.12091","journal-title":"Ann N Y Acad Sci"},{"key":"30_CR98","doi-asserted-by":"publisher","first-page":"17762","DOI":"10.1038\/s41598-017-17999-3","volume":"7","author":"E Castillo","year":"2017","unstructured":"Castillo E, Leon J, Mazzei G, et al (2017) Comparative profiling of cortical gene expression in Alzheimer\u2019s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation. Sci Rep 7:17762. https:\/\/doi.org\/10.1038\/s41598-017-17999-3","journal-title":"Sci Rep"},{"key":"30_CR99","doi-asserted-by":"publisher","first-page":"105303","DOI":"10.1016\/j.nbd.2021.105303","volume":"153","author":"AP Tsai","year":"2021","unstructured":"Tsai AP, Lin PB-C, Dong C, et al (2021) INPP5D expression is associated with risk for Alzheimer\u2019s disease and induced by plaque-associated microglia. Neurobiol Dis 153:105303. https:\/\/doi.org\/10.1016\/j.nbd.2021.105303","journal-title":"Neurobiol Dis"},{"key":"30_CR100","doi-asserted-by":"publisher","unstructured":"Sebastian Monasor L, M\u00fcller SA, Colombo AV, et al (2020) Fibrillar A\u03b2 triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Elife 9:. https:\/\/doi.org\/10.7554\/eLife.54083","DOI":"10.7554\/eLife.54083"},{"key":"30_CR101","doi-asserted-by":"publisher","first-page":"e10606","DOI":"10.15252\/emmm.201910606","volume":"12","author":"A Sierksma","year":"2020","unstructured":"Sierksma A, Lu A, Mancuso R, et al (2020) Novel Alzheimer risk genes determine the microglia response to amyloid-\u03b2 but not to TAU pathology. EMBO Mol Med 12:e10606. https:\/\/doi.org\/10.15252\/emmm.201910606","journal-title":"EMBO Mol Med"},{"key":"30_CR102","doi-asserted-by":"publisher","unstructured":"Iguchi A, Takatori S, Kimura S, et al (2021) INPP5D Modulates TREM2 Loss-of-Function Phenotypes in a Mouse Model of Alzheimer Disease. SSRN Electronic Journal. https:\/\/doi.org\/10.2139\/ssrn.3844721","DOI":"10.2139\/ssrn.3844721"},{"key":"30_CR103","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3233\/JAD-161211","volume":"58","author":"Y Yoshino","year":"2017","unstructured":"Yoshino Y, Yamazaki K, Ozaki Y, et al (2017) INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer\u2019s Disease Subjects. J Alzheimers Dis 58:687\u2013694. https:\/\/doi.org\/10.3233\/JAD-161211","journal-title":"J Alzheimers Dis"},{"key":"30_CR104","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1073\/pnas.0902636106","volume":"106","author":"RM O\u2019Connell","year":"2009","unstructured":"O\u2019Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106:7113\u20138. https:\/\/doi.org\/10.1073\/pnas.0902636106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30_CR105","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/glia.23968","volume":"69","author":"J Wi\u00dffeld","year":"2021","unstructured":"Wi\u00dffeld J, Nozaki I, Mathews M, et al (2021) Deletion of Alzheimer\u2019s disease-associated CD33 results in an inflammatory human microglia phenotype. Glia 69:1393\u20131412. https:\/\/doi.org\/10.1002\/glia.23968","journal-title":"Glia"},{"key":"30_CR106","doi-asserted-by":"publisher","unstructured":"Castranio EL, Hasel P, Haure-Mirande J-V, et al (2022) Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer\u2019s disease. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12821","DOI":"10.1002\/alz.12821"},{"key":"30_CR107","doi-asserted-by":"publisher","unstructured":"Chen WT, Lu A, Craessaerts K, et al (2020) Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer\u2019s Disease. Cell 182:. https:\/\/doi.org\/10.1016\/j.cell.2020.06.038","DOI":"10.1016\/j.cell.2020.06.038"},{"key":"30_CR108","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41593-021-00905-6","volume":"24","author":"P Hasel","year":"2021","unstructured":"Hasel P, Rose IVL, Sadick JS, et al (2021) Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci 24:1475\u20131487. https:\/\/doi.org\/10.1038\/s41593-021-00905-6","journal-title":"Nat Neurosci"},{"key":"30_CR109","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41593-022-01131-4","volume":"25","author":"NM Dr\u00e4ger","year":"2022","unstructured":"Dr\u00e4ger NM, Sattler SM, Huang CT-L, et al (2022) A CRISPRi\/a platform in human iPSC-derived microglia uncovers regulators of disease states. Nat Neurosci 25:1149\u20131162. https:\/\/doi.org\/10.1038\/s41593-022-01131-4","journal-title":"Nat Neurosci"},{"key":"30_CR110","doi-asserted-by":"publisher","unstructured":"Lin PBC, Tsai APY, Nho K, et al (2021) INPP5D regulates the amyloid pathology in Alzheimer\u2019s disease. Alzheimers Dement 17:. https:\/\/doi.org\/10.1002\/alz.058724","DOI":"10.1002\/alz.058724"},{"key":"30_CR111","doi-asserted-by":"publisher","unstructured":"Pedicone C, Fernandes S, Dungan OM, et al (2020) Pan-SHIP1\/2 inhibitors promote microglia effector functions essential for CNS homeostasis. J Cell Sci 133: https:\/\/doi.org\/10.1242\/jcs.238030","DOI":"10.1242\/jcs.238030"},{"key":"30_CR112","doi-asserted-by":"publisher","first-page":"104170","DOI":"10.1016\/j.isci.2022.104170","volume":"25","author":"C Pedicone","year":"2022","unstructured":"Pedicone C, Fernandes S, Matera A, et al (2022) Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia. iScience 25:104170. https:\/\/doi.org\/10.1016\/j.isci.2022.104170","journal-title":"iScience"},{"key":"30_CR113","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1523\/JNEUROSCI.2557-04.2004","volume":"24","author":"J Koenigsknecht","year":"2004","unstructured":"Koenigsknecht J, Landreth G (2004) Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. The Journal of Neuroscience 24:9838\u201346. https:\/\/doi.org\/10.1523\/JNEUROSCI.2557-04.2004","journal-title":"The Journal of Neuroscience"},{"key":"30_CR114","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar S, Jiang Q, Lee CYD, et al (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29:4252\u201362. https:\/\/doi.org\/10.1523\/JNEUROSCI.5572-08.2009","journal-title":"J Neurosci"}],"container-title":["Advances in Experimental Medicine and Biology","GeNeDis 2022"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-31978-5_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:09:48Z","timestamp":1701086988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-31978-5_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031319778","9783031319785"],"references-count":114,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-31978-5_30","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"1 August 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"GeNeDis","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Worldwide Congress on \u201cGenetics, Geriatrics and Neurodegenerative Diseases Research\"","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Zakinthos","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Greece","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2022","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"20 October 2022","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"22 October 2022","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"genedis2022","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/www.genedis.eu\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}